| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | FAB3934A | |||
| Carrier Free | MAB3934-SP | |||
| Carrier Free | FAB3934V-100UG | |||
| Carrier Free | FAB3934U-100UG | |||
| Carrier Free | FAB3934T-100UG | |||
| Carrier Free | FAB3934S-100UG | |||
| Carrier Free | FAB3934R-100UG | |||
| Carrier Free | FAB3934N-100UG | |||
| Carrier Free | FAB3934G-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-54626-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21770-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89669-50ul | |||
![Immunohistochemistry: CEACAM-6/CD66c Antibody (1H7-4B) [NBP2-54626] - Analysis in human lung: Using Anti-CEACAM6 [1H7-4B] (10 ug/ml) developed with DAB-staining procedure. Dark line indicated shows CEACAM6 expression.](http://images.novusbio.com/fullsize/CEACAM-6-CD66c-Antibody-1H7-4B-Immunohistochemistry-NBP2-54626-img0003.jpg "Immunohistochemistry: CEACAM-6/CD66c Antibody (1H7-4B) [NBP2-54626] - Analysis in human lung: Using Anti-CEACAM6 [1H7-4B] (10 ug/ml) developed with DAB-staining procedure. Dark line indicated shows CEACAM6 expression.")
![Flow Cytometry: CEACAM-6/CD66c Antibody (1H7-4B) [NBP2-54626] - Binding of 10 ug/ml primary positive control mAb (upper panel), Anti-CEACAM6 [1H7-4B] (lower panel), negative isotype matched control mAb (thin line) on different CHO-human CEACAM transfected cells (the CEACAM family member expressed is stated above).](http://images.novusbio.com/fullsize/CEACAM-6-CD66c-Antibody-1H7-4B-Flow-Cytometry-NBP2-54626-img0002.jpg)
![ELISA: CEACAM-6/CD66c Antibody (1H7-4B) [NBP2-54626] - Solid phase was coated with 3 ug/ml Anti-CEA binding human CEACAM1-CEACAM8. After washing, blocking and coating human CEACAM1 antigen, detecting antibody Anti-CEACAM6 [1H7-4B] (10 ug/ml) followed by HRP-coupled goat anti-mouse Ig was added. TMB was used for visualizing the binding measured by Tecan-ELISA reader at 450 nm.](http://images.novusbio.com/fullsize/CEACAM-6-CD66c-Antibody-1H7-4B-ELISA-NBP2-54626-img0001.jpg)
![Immunoprecipitation: CEACAM-6/CD66c Antibody (1H7-4B) [NBP2-54626] - Human granulocyte lysate: Utilizing 10 ug/ml Anti-CEACAM6 [1H7-4B]. Detection of the sample using 5 ug/ml pAb Anti-CEA followed by HRP-coupled secondary pAb. Visualized by Chemiluminescence detection.](http://images.novusbio.com/fullsize/CEACAM-6-CD66c-Antibody-1H7-4B-Immunoprecipitation-NBP2-54626-img0004.jpg)
![Western Blot: CEACAM-6/CD66c Antibody (1H7-4B) [NBP2-54626] - Detection using 10 μg/ml NBP2-54626 followed by HRP-coupled secondary antibody. Visualized by Chemiluminescence detection.](http://images.novusbio.com/fullsize/antibody/nbp2-54626_mouse-ceacam6-cd66c-mab-1h7-4b-bsa-free-western-blot-382023125340..jpg)
![Western Blot: CEACAM6/CD66c Antibody (4Z3V7) [NBP3-16625] - Analysis of extracts of various cell lines, using CEACAM6/CD66c Rabbit mAb (NBP3-16625) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 1s.](http://images.novusbio.com/fullsize/CEACAM6-CD66c-Antibody-4Z3V7-Western-Blot-NBP3-16625-img0004.jpg "Western Blot: CEACAM6/CD66c Antibody (4Z3V7) [NBP3-16625] - Analysis of extracts of various cell lines, using CEACAM6/CD66c Rabbit mAb (NBP3-16625) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 1s.")
![Immunocytochemistry/Immunofluorescence: CEACAM6/CD66c Antibody (4Z3V7) [NBP3-16625] - Immunofluorescence analysis of rat rectum cells using CEACAM6/CD66c Rabbit mAb (NBP3-16625) at dilution of 1:100 (40x lens). Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/CEACAM6-CD66c-Antibody-4Z3V7-Immunocytochemistry-Immunofluorescence-NBP3-16625-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: CEACAM6/CD66c Antibody (4Z3V7) [NBP3-16625] - Immunofluorescence analysis of human colon carcinoma cells using CEACAM6/CD66c Rabbit mAb (NBP3-16625) at dilution of 1:100 (40x lens). Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/CEACAM6-CD66c-Antibody-4Z3V7-Immunocytochemistry-Immunofluorescence-NBP3-16625-img0002.jpg)
![Immunocytochemistry/ Immunofluorescence: CEACAM6/CD66c Antibody (4Z3V7) [NBP3-16625] - Immunofluorescence analysis of mouse large intestine cells using CEACAM6/CD66c Rabbit mAb at dilution of 1:100 (40x lens). Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/nbp3-16625_rabbit-ceacam6-cd66c-mab-4z3v7-82202520847.jpg)
![N/A CEACAM6/CD66c [Biotin]](http://images.novusbio.com/fullsize2/DATA_CEACAM6_DY3934_ELISA_1992.jpg "N/A CEACAM6/CD66c [Biotin]")
![Western Blot: CEACAM-6/CD66c Antibody [NBP1-55290] - Sample Tissue: Jurkat, Lane A: Primary Antibody, Lane B: Primary Antibody + Blocking Peptide, Primary Antibody Concentration: 1.25ug/mL, Peptide Concentration: 1.0ug/mL, Lysate Quantity: 25ug/lane, Gel Concentration: 12%](http://images.novusbio.com/fullsize/CEACAM-6-CD66c-Antibody-Western-Blot-NBP1-55290-img0005.jpg "Western Blot: CEACAM-6/CD66c Antibody [NBP1-55290] - Sample Tissue: Jurkat, Lane A: Primary Antibody, Lane B: Primary Antibody + Blocking Peptide, Primary Antibody Concentration: 1.25ug/mL, Peptide Concentration: 1.0ug/mL, Lysate Quantity: 25ug/lane, Gel Concentration: 12%")
![Immunohistochemistry-Paraffin: CEACAM-6/CD66c Antibody [NBP1-55290] - Human Lung Alveolar cells (indicated with arrows), 4-8ug/ml.](http://images.novusbio.com/fullsize/CEACAM-6-CD66c-Antibody-Immunohistochemistry-Paraffin-NBP1-55290-img0003.jpg)
![Western Blot: CEACAM-6/CD66c Antibody [NBP1-55290] - Jurkat cell lysate, Antibody Titration: 1.25ug/ml](http://images.novusbio.com/fullsize/CEACAM-6-CD66c-Antibody-Western-Blot-NBP1-55290-img0002.jpg)
![Western Blot: CEACAM6/CD66c Antibody (SR1614) [NBP3-21770] - Western blot analysis using NBP3-21770 in MCF7 cell lysate.](http://images.novusbio.com/fullsize/nbp3-21770_rabbit-ceacam6-cd66c-mab-sr1614-57202317161841.jpg "Western Blot: CEACAM6/CD66c Antibody (SR1614) [NBP3-21770] - Western blot analysis using NBP3-21770 in MCF7 cell lysate.")
![Immunocytochemistry/Immunofluorescence: CEACAM6/CD66c Antibody (1G2) [H00004680-M02] - Analysis of monoclonal antibody to CEACAM6 on HeLa cell . Antibody concentration 10 ug/ml.](http://images.novusbio.com/fullsize/CEACAM6-CD66c-Antibody-1G2-Immunocytochemistry-Immunofluorescence-H00004680-M02-img0002.jpg "Immunocytochemistry/Immunofluorescence: CEACAM6/CD66c Antibody (1G2) [H00004680-M02] - Analysis of monoclonal antibody to CEACAM6 on HeLa cell . Antibody concentration 10 ug/ml.")
![ELISA: CEACAM6/CD66c Antibody (1G2) [H00004680-M02] - CEACAM-6/CD66c Antibody (1G2) [H00004680-M02] - Detection limit for recombinant GST tagged CEACAM6 is 0.1 ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/CEACAM6-CD66c-Antibody-1G2-ELISA-H00004680-M02-img0004.jpg)
![Flow Cytometry: CEACAM6/CD66c Antibody (408) [NBP2-89669] - Analysis of Human CEACAM6 expression on human peripheral blood granulocytes. Cells were stained with purified anti-Human CEACAM6, then a FITC-conjugated second step antibody. The histogram were derived from gated events with the forward and side light-scatter characteristics of viable granulocytes.](http://images.novusbio.com/fullsize/CEACAM6-CD66c-Antibody-408-Flow-Cytometry-NBP2-89669-img0001.jpg "Flow Cytometry: CEACAM6/CD66c Antibody (408) [NBP2-89669] - Analysis of Human CEACAM6 expression on human peripheral blood granulocytes. Cells were stained with purified anti-Human CEACAM6, then a FITC-conjugated second step antibody. The histogram were derived from gated events with the forward and side light-scatter characteristics of viable granulocytes.")
![Immunocytochemistry/Immunofluorescence: CEACAM6/CD66c Antibody (408) [NBP2-89669] - Staining of Human CEACAM6 in SKBR3 cells. Cells were fixed with 4% PFA, permeabilzed with 0.3% Triton X-100 in PBS, blocked with 10% serum, and incubated with NBP2-89669 antibody (1:300) at 4c overnight. Then cells were stained with the Alexa Fluor(R) 488-conjugated Goat Anti-rabbit IgG secondary antibody (green) and counterstained with DAPI (blue).](http://images.novusbio.com/fullsize/nbp2-89669_rabbit-monoclonal-ceacam6-cd66c-antibody-408-235202516144331.png)
![Flow Cytometry: CEACAM6/CD66c Antibody (B6.2) [NBP3-09125] - Separation of neutrophil granulocytes stained anti-human CD66c (B6.2) purified antibody (concentration in sample 3 ug/ml, GAM APC, red-filled) from neutrophil granulocytes unstained by primary antibody (GAM APC, black-dashed) in flow cytometry analysis (surface staining).](http://images.novusbio.com/fullsize/CEACAM6-CD66c-Antibody-B6-2-Flow-Cytometry-NBP3-09125-img0002.jpg "Flow Cytometry: CEACAM6/CD66c Antibody (B6.2) [NBP3-09125] - Separation of neutrophil granulocytes stained anti-human CD66c (B6.2) purified antibody (concentration in sample 3 ug/ml, GAM APC, red-filled) from neutrophil granulocytes unstained by primary antibody (GAM APC, black-dashed) in flow cytometry analysis (surface staining).")
![Flow Cytometry: CEACAM6/CD66c Antibody (B6.2) [NBP3-09125] - Surface staining pattern of human peripheral whole blood stained using anti-human CD66c (B6.2) purified antibody (concentration in sample 3 ug/ml, GAM APC).](http://images.novusbio.com/fullsize/CEACAM6-CD66c-Antibody-B6-2-Flow-Cytometry-NBP3-09125-img0001.jpg)
